The over-the-counter medical application is intended for individuals aged 18 years and older who have not been previously diagnosed with sleep apnea.
Atovaquone Oral Suspension is a quinone antimicrobial drug indicated for prevention and treatment of Pneumocystis jiroveci pneumonia in adults and children 13 years of age and older who cannot ...
The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Vanda Pharmaceuticals regarding the New Drug Application (NDA) for tradipitant for the treatment of gastroparesis.